Perioperative blood transfusion and prognosis of resected stage Ia lung cancer

The sequence of vessel interruption during lobectomy for non–small cell lung cancer: is it indeed important?

“…This issue was discussed in previous reports and a dispute exists about the impact of perioperative blood transfusion on patient prognosis. [17][18][19] Our finding with regard to the nil effect of a previous malignancy on the outcome is in accordance with other studies. [20][21][22] The inclusion of frozen section and lung manipulation in our analysis mandates explanation.…”

The sequence of vessel interruption during lobectomy for non–small cell lung cancer: is it indeed important?

“…This issue was discussed in previous reports and a dispute exists about the impact of perioperative blood transfusion on patient prognosis. [17][18][19] Our finding with regard to the nil effect of a previous malignancy on the outcome is in accordance with other studies. [20][21][22] The inclusion of frozen section and lung manipulation in our analysis mandates explanation.…”

The influence of blood transfusion on survival in operated non–small cell lung cancer patients

“…The blood transfusion rate accompanying pulmonary resection varies in particular series from 36% to 55%. [8][9][10][11][12][13] In our series the frequency of transfusions (67%) was higher than in most studies including operable NSCLC. This outcome is due to several factors including mainly frequent preoperative blood donation, relatively high incidence of squamous cell carcinoma typically located centrally and necessitating more extensive resection, relatively high percentage of stage III disease, and routinely performed complete mediastinal lymph node dissection.…”

Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies

“…Overall 30-day and 90-day mortality rates were 9.2% (95% confidence interval (CI) 7.8-10.6%) and 15% (95% CI 13.2-16.8%), respectively. Statistically significant differences in early mortality were observed when transfused patients were compared with nontransfused patients; 19 The incidence of infectious complications was 13.7% in transfused patients and 5.6% in nontransfused patients (p50.004). Blood transfusion was disclosed as the strongest predictor of those post-operative infectious complications (HR 3; 95% CI 1.5-6.2; p50.003).…”

The sequence of vessel interruption during lobectomy for non–small cell lung cancer: is it indeed important?

“…This issue was discussed in previous reports and a dispute exists about the impact of perioperative blood transfusion on patient prognosis. [17][18][19] Our finding with regard to the nil effect of a previous malignancy on the outcome is in accordance with other studies. [20][21][22] The inclusion of frozen section and lung manipulation in our analysis mandates explanation.…”

The influence of blood transfusion on survival in operated non–small cell lung cancer patients

“…The blood transfusion rate accompanying pulmonary resection varies in particular series from 36% to 55%. [8][9][10][11][12][13] In our series the frequency of transfusions (67%) was higher than in most studies including operable NSCLC. This outcome is due to several factors including mainly frequent preoperative blood donation, relatively high incidence of squamous cell carcinoma typically located centrally and necessitating more extensive resection, relatively high percentage of stage III disease, and routinely performed complete mediastinal lymph node dissection.…”

Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies

“…Overall 30-day and 90-day mortality rates were 9.2% (95% confidence interval (CI) 7.8-10.6%) and 15% (95% CI 13.2-16.8%), respectively. Statistically significant differences in early mortality were observed when transfused patients were compared with nontransfused patients; 19 The incidence of infectious complications was 13.7% in transfused patients and 5.6% in nontransfused patients (p50.004). Blood transfusion was disclosed as the strongest predictor of those post-operative infectious complications (HR 3; 95% CI 1.5-6.2; p50.003).…”

The sequence of vessel interruption during lobectomy for non–small cell lung cancer: is it indeed important?

“…This issue was discussed in previous reports and a dispute exists about the impact of perioperative blood transfusion on patient prognosis. [17][18][19] Our finding with regard to the nil effect of a previous malignancy on the outcome is in accordance with other studies. [20][21][22] The inclusion of frozen section and lung manipulation in our analysis mandates explanation.…”

The influence of blood transfusion on survival in operated non–small cell lung cancer patients

“…The blood transfusion rate accompanying pulmonary resection varies in particular series from 36% to 55%. [8][9][10][11][12][13] In our series the frequency of transfusions (67%) was higher than in most studies including operable NSCLC. This outcome is due to several factors including mainly frequent preoperative blood donation, relatively high incidence of squamous cell carcinoma typically located centrally and necessitating more extensive resection, relatively high percentage of stage III disease, and routinely performed complete mediastinal lymph node dissection.…”

Impact of blood transfusions on outcome after pneumonectomy for thoracic malignancies

“…Overall 30-day and 90-day mortality rates were 9.2% (95% confidence interval (CI) 7.8-10.6%) and 15% (95% CI 13.2-16.8%), respectively. Statistically significant differences in early mortality were observed when transfused patients were compared with nontransfused patients; 19 The incidence of infectious complications was 13.7% in transfused patients and 5.6% in nontransfused patients (p50.004). Blood transfusion was disclosed as the strongest predictor of those post-operative infectious complications (HR 3; 95% CI 1.5-6.2; p50.003).…”